In the 298-page book that is primarily written in English, all of the 67 research groups of the MDC and the clinical groups in the Experimental and Clinical Research Center (ECRC) of the MDC and of the Charité – Universitätsmedizin Berlin give an overview of their work in 2010 – 2011. Research activities at the MDC focus on cardiovascular and metabolic diseases, cancer, diseases of the nervous system and systems biology.
The presentation of the research groups, technology platforms and technology transfer projects provides insight into the research activities of the MDC. “In recent years the scientists of the MDC have again achieved internationally acclaimed results and published them in leading journals,” said Professor Walter Rosenthal, scientific director of the MDC, in his introduction to the research report. In 2010 the MDC ranked 14th on the Thomson Reuters list in the field of molecular biology and genetics, making it the only German research institution to be among the world’s “Top Twenty”.
Furthermore, Professor Rosenthal emphasized the MDC’s extensive participation in excellence clusters and collaborative research centers, the acquisition of eight ERC grants and the award of the Leibniz Prize –the most highly endowed German research prize – to Professor Nikolaus Rajewsky, head of the Berlin Institute for Medical Systems Biology (BIMSB) at the MDC, during the period covered by the report.
“The founding charter of the MDC, which was formulated in 1992, is more relevant than ever,” Professor Rosenthal went on to say. “Its aim is to make laboratory results quickly available to doctors and patients in the hospital – as we say the ʽbench to bedsideʼ approach.” In 2007 the Experimental and Clinical Research Center (ECRC), modeled after Clinical Research Centers (CRC) in the U.S., was founded on Campus Berlin-Buch.
As a joint institution of the MDC and the Charité, the ECRC promotes cooperation between basic scientists and clinical researchers in order to accelerate the transfer of insights gained from laboratory research into medical practice. In the future, according to Prof. Rosenthal, the MDC will take its longstanding and close partnership with the Charité to a new level by developing a common institutional platform. This will ensure that “basic biomedical research and clinical research will benefit even more from each other than in the past.”
The MDC was founded on the Campus Berlin-Buch in 1992. It is a member of the Helmholtz Association of German Research Centres and receives its basic operational funding of approximately 71 million euros a year in a fixed ratio of 90 percent from the Federal Ministry of Education and Research and 10 percent from the state of Berlin. In addition, extramural grants acquired by the researchers are in the two-digit million-euro range each year. At present, approximately 1350 people work at the MDC. These include around 1100 research staff members, of whom around 700 are scientists from Germany and from other countries. Along with its partnership with the Charité, the MDC cooperates closely with the Berlin universities, with the Leibniz-Institut für Molekulare Pharmakologie (FMP), the biotechnology park on Campus Berlin-Buch with its 55 companies and with universities and research institutions inside and outside of Germany.
To receive this new research report, please request a copy from the MDC Press Department.Contact:
Barbara Bachtler | Max-Delbrück-Centrum
Single-stranded DNA and RNA origami go live
15.12.2017 | Wyss Institute for Biologically Inspired Engineering at Harvard
New antbird species discovered in Peru by LSU ornithologists
15.12.2017 | Louisiana State University
DNA molecules that follow specific instructions could offer more precise molecular control of synthetic chemical systems, a discovery that opens the door for engineers to create molecular machines with new and complex behaviors.
Researchers have created chemical amplifiers and a chemical oscillator using a systematic method that has the potential to embed sophisticated circuit...
MPQ scientists achieve long storage times for photonic quantum bits which break the lower bound for direct teleportation in a global quantum network.
Concerning the development of quantum memories for the realization of global quantum networks, scientists of the Quantum Dynamics Division led by Professor...
Researchers have developed a water cloaking concept based on electromagnetic forces that could eliminate an object's wake, greatly reducing its drag while...
Tiny pores at a cell's entryway act as miniature bouncers, letting in some electrically charged atoms--ions--but blocking others. Operating as exquisitely sensitive filters, these "ion channels" play a critical role in biological functions such as muscle contraction and the firing of brain cells.
To rapidly transport the right ions through the cell membrane, the tiny channels rely on a complex interplay between the ions and surrounding molecules,...
The miniaturization of the current technology of storage media is hindered by fundamental limits of quantum mechanics. A new approach consists in using so-called spin-crossover molecules as the smallest possible storage unit. Similar to normal hard drives, these special molecules can save information via their magnetic state. A research team from Kiel University has now managed to successfully place a new class of spin-crossover molecules onto a surface and to improve the molecule’s storage capacity. The storage density of conventional hard drives could therefore theoretically be increased by more than one hundred fold. The study has been published in the scientific journal Nano Letters.
Over the past few years, the building blocks of storage media have gotten ever smaller. But further miniaturization of the current technology is hindered by...
11.12.2017 | Event News
08.12.2017 | Event News
07.12.2017 | Event News
15.12.2017 | Power and Electrical Engineering
15.12.2017 | Materials Sciences
15.12.2017 | Life Sciences